156 related articles for article (PubMed ID: 3893505)
1. The prognostic value of serum beta 2 microglobulin compared with other presentation features in myelomatosis.
Cuzick J; Cooper EH; MacLennan IC
Br J Cancer; 1985 Jul; 52(1):1-6. PubMed ID: 3893505
[TBL] [Abstract][Full Text] [Related]
2. Long-term prognostic value of serum beta 2 microglobulin in myelomatosis.
Cuzick J; De Stavola BL; Cooper EH; Chapman C; MacLennan IC
Br J Haematol; 1990 Aug; 75(4):506-10. PubMed ID: 2119793
[TBL] [Abstract][Full Text] [Related]
3. Prognostic features in the third MRC myelomatosis trial. Medical Research Council's Working Party on Leukaemia in Adults.
Br J Cancer; 1980 Dec; 42(6):831-40. PubMed ID: 7459218
[TBL] [Abstract][Full Text] [Related]
4. Serum beta 2-microglobulin in myelomatosis: potential value in stratification and monitoring.
Norfolk D; Child JA; Cooper EH; Kerruish S; Ward AM
Br J Cancer; 1980 Oct; 42(4):510-5. PubMed ID: 6159910
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of serum beta 2-microglobulin as a prognostic indicator in myelomatosis.
Child JA; Crawford SM; Norfolk DR; O'Quigley J; Scarffe JH; Struthers LP
Br J Cancer; 1983 Jan; 47(1):111-4. PubMed ID: 6185132
[TBL] [Abstract][Full Text] [Related]
6. [Role of the assay of serum beta 2 microglobulin in the clinical evaluation of myeloma].
Bataille R; Grenier J
Presse Med; 1986 Oct; 15(34):1723-5. PubMed ID: 2947132
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of correction of serum beta 2-microglobulin levels for serum creatinine in multiple myeloma.
Scudla V; Vavrdová V; Budíková M; Indrák K
Acta Univ Palacki Olomuc Fac Med; 1991; 131():257-64. PubMed ID: 1840347
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of pretreatment serum beta 2-microglobulin levels in multiple myeloma.
Scarffe JH; Anderson H; Palmer MK; Crowther D
Eur J Cancer Clin Oncol; 1983 Oct; 19(10):1361-4. PubMed ID: 6357802
[TBL] [Abstract][Full Text] [Related]
9. Serum beta 2-microglobulin: a real improvement in the management of multiple myeloma?
van Dobbenburgh OA; Rodenhuis S; Ockhuizen T; Weltevreden E; Houwen B; Fidler V; Meijer S; Marrink J
Br J Haematol; 1985 Dec; 61(4):611-20. PubMed ID: 3910076
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in multiple myeloma: role of beta 2-microglobulin and thymidine kinase.
Diem H; Fateh-Moghadam A; Lamerz R
Clin Investig; 1993 Nov; 71(11):918-23. PubMed ID: 8312685
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic importance of beta-2-microglobulin in multiple myeloma].
Avilés A; Zepeda G; Guzmán R; Talavera A; García EL; Díaz-Maqueo JC
Rev Invest Clin; 1992; 44(2):215-20. PubMed ID: 1439309
[TBL] [Abstract][Full Text] [Related]
12. Serum beta2 microglobulin and survival duration in multiple myeloma: a simple reliable marker for staging.
Bataille R; Durie BG; Grenier J
Br J Haematol; 1983 Nov; 55(3):439-47. PubMed ID: 6357266
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of pretreatment serum beta 2 microglobulin in myeloma: a Southwest Oncology Group Study.
Durie BG; Stock-Novack D; Salmon SE; Finley P; Beckord J; Crowley J; Coltman CA
Blood; 1990 Feb; 75(4):823-30. PubMed ID: 2405920
[TBL] [Abstract][Full Text] [Related]
14. Long-term survival in myelomatosis. A report to the MRC working party on leukaemia in adults.
Buckman R; Cuzick J; Galton DA
Br J Haematol; 1982 Dec; 52(4):589-99. PubMed ID: 6958312
[TBL] [Abstract][Full Text] [Related]
15. [Multiple myeloma with 5-year survival. Study of initial prognostic factors. Role of beta-2-microglobulin].
Franco M; Fuzibet JG; Cassuto JP; Pesce A; Ziegler G; Dujardin P
Rev Rhum Mal Osteoartic; 1985 Nov; 52(11):619-23. PubMed ID: 3909365
[TBL] [Abstract][Full Text] [Related]
16. Urinary pseudouridine excretion in myelomatosis.
Sørensen SH; Brown DA; Cooper EH; Kelly KA; MacLennan IC
Br J Cancer; 1985 Dec; 52(6):863-6. PubMed ID: 3907686
[TBL] [Abstract][Full Text] [Related]
17. Beta-2-microglobulin: a valuable parameter of stage, prognosis and response to treatment in myelomatosis.
Bjerrum OW; Plesner T
Scand J Haematol; 1985 Jul; 35(1):22-5. PubMed ID: 3901240
[No Abstract] [Full Text] [Related]
18. Beta 2 microglobulin in multiple myeloma.
Alexanian R; Barlogie B; Fritsche H
Am J Hematol; 1985 Dec; 20(4):345-51. PubMed ID: 3907332
[TBL] [Abstract][Full Text] [Related]
19. [The prognostic significance of the beta 2-microglobulin level of the blood serum in multiple myeloma patients].
Lubo-Lesnichenko IF; Bessmel'tsev SS; Abdulkadyrov KM; Blinov MN; Stel'mashenko LV
Ter Arkh; 1996; 68(10):28-31. PubMed ID: 9026938
[TBL] [Abstract][Full Text] [Related]
20. Plasma cell labeling index and beta 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma.
Greipp PR; Lust JA; O'Fallon WM; Katzmann JA; Witzig TE; Kyle RA
Blood; 1993 Jun; 81(12):3382-7. PubMed ID: 8507875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
